>

AbbVie Stock Quote Today

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 40px;;'>ABB</div>
AbbVie is selling for under 75.13 as of the 5th of April 2020; that is 2.40 percent increase since the beginning of the trading day. The stock's lowest day price was 71.46. AbbVie has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 30 days. Equity ratings for AbbVie are calculated based on the Macroaxis scoring framework. The performance scores are derived for the period starting the 6th of January 2020 and ending today, the 5th of April 2020. Click here to learn more.
Analyze Filter   Earning Report: 23rd of April 2020

  Performance0 100 

AbbVie Profile

Upcoming quarterly earning report is expected on 23rd of April 2020. AbbVie Inc., a research-based biopharmaceutical company, develops and markets pharmaceutical products in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 30000 people. more on AbbVie
AbbVie Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
AbbVie SEC Filings
AbbVie SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAbbVie
ChairmanRichard GonzalezView All
Thematic Classifications
Active investing themes AbbVie currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering AbbVie
Piotroski F Score
Academic score to determine the current strength of AbbVie financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
AbbVie ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: AStrong
Profitability
Few selected profitability drivers of AbbVie representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
AbbVie (ABBV) is traded on BATS Exchange in USA. It is located in 1 North Waukegan Road, North Chicago, IL 60064-6400, United States and employs 30,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with current market capitalization of 130.77 B. AbbVie conducts business under Healthcare sector and is part of Drug Manufacturers?General industry. The entity has 1.48 B outstanding shares of which 81.62 M shares are presently shorted by private and institutional investors with about 6.62 trading days to cover. AbbVie Inc. Commo currently holds about 39.92 B in cash with 13.32 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 26.99.
Check AbbVie Probability Of Bankruptcy

Ownership Allocation (%)

AbbVie Stock Price Odds Analysis

Odds Down 75.13HorizonTargetOdds Up 75.13
11.75%30 days
 75.13 
88.18%
Based on normal probability distribution, the odds of AbbVie to move above current price in 30 days from now is about 88.18 (This AbbVie probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 30 days) .

AbbVie Stock Top Holders

AbbVie Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Park National CorpCommon Shares205.9 K15.7 M
Thomasville National BankCommon Shares169 K12.8 M
View AbbVie Diagnostics

AbbVie Income Statement Over Time

AbbVie Income Statement is one of the three primary financial statements used for reporting AbbVie's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AbbVie revenue and expense. AbbVie Income Statement primarily focuses on the company's revenues and expenses during a particular period. AbbVie Gross Profit is fairly stable at the moment as compared to the last year. AbbVie reported Gross Profit of 25.83 Billion in 2019. Interest Expense is likely to grow to about 1.6 B in 2020, whereas Consolidated Income is likely to drop slightly above 7 B in 2020. View More Fundamentals
Consolidated Income    Earning Before Interest and Taxes USD    Interest Expense    

AbbVie Stock Against Markets

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

AbbVie Upcoming and Recent Events

AbbVie Company Earnings Announcements Dates

Upcoming Quarterly Earning Report23rd of April 2020
Next Earnings Report24th of July 2020
Next Fiscal Quarter End31st of March 2020
Next Fiscal Year End5th of February 2021
Last Quarter Report Date31st of December 2019
Last Earning Anouncement Date31st of March 2019

AbbVie Corporate Filings

AbbVie SEC Reporting

Financial Statements and Exhibits. Other Events
Unclassified Corporate Event. Termination of a Material Definitive Agreement
Submission of Matters to a Vote of Security Holders
Results of Operations and Financial Condition

AbbVie Distributions to stockholders

AbbVie Corporate Directors

Frederick Waddell Independent Director
Robert Alpern Independent Director
Glenn Tilton Independent Director
Please continue to Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page